Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Guardant Health, Inc. - Common Stock (NQ:GH)

108.17 -0.57 (-0.52%)
Streaming Delayed Price Updated: 11:14 AM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Guardant Health, Inc. - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
19 20 Next >
News headline image
Guardant Health to present real-world data supporting performance of Shield™ blood test for colorectal cancer screening at 2024 Digestive Disease Week
From Guardant Health, Inc.
Via Business Wire
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
GH Stock Earnings: Guardant Health Beats EPS, Beats Revenue for Q1 2024 ↗
GH stock results show that Guardant Health beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Key Takeaways From Guardant Health Analyst Ratings ↗
 
Via Benzinga
News headline image
Analyst Expectations For Guardant Health's Future ↗
 
Via Benzinga
News headline image
4 Analysts Have This To Say About Guardant Health ↗
 
Via Benzinga
News headline image
Guardant Health: Q4 Earnings Insights ↗
 
Via Benzinga
News headline image
Guardant Health Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health to Participate in Upcoming Investor Conferences
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health Surpasses 500 Peer-Reviewed Publications Milestone
From Guardant Health, Inc.
Via Business Wire
News headline image
Matterport, Sea Limited, Ingevity And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
News headline image
Decoding 4 Analyst Evaluations For Guardant Health ↗
 
Via Benzinga
News headline image
FDA Advisory Panel Review of Guardant Health’s Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health to Report First Quarter 2024 Financial Results on May 9, 2024
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health to Present Data Highlighting Application of Epigenomics to Advance Precision Oncology at 2024 AACR Annual Meeting
From Guardant Health, Inc.
Via Business Wire
News headline image
Exact Sciences, A Cathie Wood Stock, Surges As Rival Colon Cancer Test Pales ↗
The companies are working to detect colon cancer and precancerous markers in blood and/or stool. 
Via Investor's Business Daily
News headline image
Better Than ChatGPT? New Super AI Bot Says Buy These 3 Stocks. ↗
These stocks are solid buys according to the advanced AI model Claude 3, which has been touted as potentially superior to ChatGPT. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday ↗
U.S. stocks were slightly higher, with the S&P 500 gaining around 0.1% on Thursday. Shares of REX American Resources Corporation (NYSE: REX) rose sharply during Thursday’s session following upbeat... 
Via Benzinga
News headline image
Insiders Buying Advance Auto Parts And 2 Other Stocks ↗
Although U.S. stocks closed higher on Tuesday, there were a few notable insider trades. 
Via Benzinga
News headline image
Guardant Health ECLIPSE Study Data Demonstrating Efficacy of Shield Blood-based Test for Colorectal Cancer Screening to be Published in The New England Journal of Medicine
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Guardant Health, Inc.
Via Business Wire
News headline image
New Survey: Patients and Physicians Overwhelmingly Agree Blood Tests Could Help Close the Colorectal Cancer Screening Gap
From Guardant Health, Inc.
Via Business Wire
News headline image
Cancer Test Focused Guardant Health Stock Falls On FDA AdCom Update For Colorectal Test ↗
Guardant Health surpasses Q4 2023 revenue expectations, reporting $155.1 million. Precision oncology revenue is up 25% to $142.2 million. Adjusted EPS loss beats consensus. Update on Shield CRC... 
Via Benzinga
News headline image
Guardant Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health to Participate in Upcoming Investor Conferences
From Guardant Health, Inc.
Via Business Wire
News headline image
Guardant Health to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024
From Guardant Health, Inc.
Via Business Wire
News headline image
3 Stocks to Buy for the Age of Personalized Medicine ↗
Personalized medicine stocks can unlock significant growth from your portfolio. Here are three companies to consider. 
Via InvestorPlace
News headline image
Guardant Health to present data at ASCO GI supporting use of liquid biopsy to predict colon cancer recurrence
From Guardant Health, Inc.
Via Business Wire
News headline image
Bull of the Day - NeoGenomics ↗
But in late December, shares took a big hit on patent litigation with competitor Natera. Let's review the primary commercial business of NEO and then that will help put the legal news into context. 
Via Talk Markets
Topics Intellectual Property
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.